> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/sourcing-quality.md).
# Sourcing Quality
Not all Ashwagandha products contain meaningful WFA exposure. For oncology use, the sourcing question is not cosmetic. It determines whether the product even matches the biology being discussed.
### What makes a product coherent?
#### 1. Plant part must be explicit
Leaf extract is the relevant starting material for WFA-standardised oncology products. Root extract is the usual base for adaptogenic Ashwagandha products and typically contains much less WFA.
A root extract standardised to total withanolides is not the same as a leaf-derived WFA-standardised product.
#### 2. WFA standardisation must be explicit
The label should state WFA content, not just total withanolides.
This distinction is critical. Total withanolide percentages can look impressive while actual WFA content remains modest.
#### 3. Delivery system must be defined
Given WFA's poor standard oral bioavailability, a product without a delivery system is hard to take seriously for oncology use.
Look for a named formulation approach such as:
* liposomal
* pro-liposomal
* chitosan-phospholipid liposomal
For more context, see [Liposomal Encapsulation of Anti-cancer Compounds](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds.md).
#### 4. Third-party testing must be available
A credible product should be able to show batch-level confirmation of:
* actual WFA content by `HPLC`
* heavy metal testing
* pesticide screening
* microbiological safety
#### 5. Dose transparency matters
The product should clearly state WFA exposure per capsule or serving. If the label forces readers to infer it indirectly, that is a quality warning.
### The biggest buying mistake
The most common mistake is buying a standard adaptogenic root extract such as KSM-66 or Sensoril and expecting oncology-relevant WFA activity.
Those products are built for stress, sleep, and broader adaptogenic use. They are not interchangeable with high-WFA, oncology-oriented formulations.
A second common mistake is buying a leaf extract without a defined delivery system. High nominal WFA content in a powder does not guarantee useful plasma exposure.
### Withaferin A Quality markers
| Feature | What to look for |
| ----------------------- | ---------------------------------------------------------------------- |
| Plant part | Leaf extract specified |
| Standardisation | Explicit `% WFA`, not just total withanolides |
| Delivery system | Liposomal, pro-liposomal, or similar strategy clearly named |
| Dose transparency | WFA mg per capsule or serving stated |
| Certificate of analysis | Batch-level `HPLC` verification available |
| Heavy metal testing | Arsenic, mercury, lead, and cadmium below limits |
| Pesticide screening | Multi-residue screen or equivalent |
| Microbial testing | Absence of key pathogens confirmed |
| Classification | Practitioner-guided or clinically supervised positioning is preferable |
### Bottom line
> If the product does not name the plant part, does not state WFA content, and does not explain the delivery system, it should not be assumed to match the evidence base for WFA in oncology.\
> \
> **See** [**W section in our Trusted Suppliers and Discounts page**](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/trusted-suppliers-and-discounts#w)\
> **for the only WFA product available worldwide that meets all the criteria.**
**IMPORTANT:** Please do not assume that any “ashwagandha” supplement will provide oncology‑relevant WFA exposure. This page was created to highlight Withaferin A‑focused targets, and specialised WFA‑standardised leaf extracts are required, not general ashwagandha root products. For support in sourcing see the **Sourcing Quality** page within this WFA in Oncology Hub.
### Key references
(Leaf vs root WFA content.)\
Source: Kulkarni S. K. et al., “Comparative study of Withaferin A and Withanolide A in different Withania somnifera plant parts,” SSRN preprint.\
(Whole-plant extract profiling and withanolide composition.)\
Source: Kurapati K. R. V. et al., “Chemical, microbial and safety profiling of a standardized Withania somnifera extract,” *Functional Foods in Health and Disease*.\
(Improved bioavailability with liposomal WFA.)\
Source: Yadav K. S. et al., “Improving Oral Bioavailability and Pharmacokinetics of Liposomal Withaferin A,” *International Journal of Pharmaceutics*.\
Access and availability:\
Source: MCS Formulas, “Withaferin A Pro Liposomal.”\
`50 mg` WFA per capsule. Available via healthcare professional request.\
### In this section
#### Core pages
* [Withaferin A (WFA) in Oncology](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology.md)
* [Evidence Summary](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/evidence-summary.md)
* [Anticancer Mechanisms](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/anti-cancer-mechanisms.md)
* [Immune Effects](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/immune-effects.md)
* [Synergistic Combinations](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/synergistic-combinations.md)
#### Cancer-type pages
* [WFA Evidence by Cancer Type](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type.md)
* [Breast Cancer](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/breast-cancer.md)
* [Ovarian Cancer](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/ovarian-cancer.md)
* [Non-Small Cell Lung Cancer](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/non-small-cell-lung-cancer.md)
* [Glioblastoma](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/glioblastoma.md)
* [Other Cancer Types](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/other-cancer-types.md)
#### Practical pages
* [Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/pharmacokinetics-and-metabolism.md)
* [Sourcing Quality](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/sourcing-quality.md)
* [Safety, Interactions and WFA Dosing](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/safety-interactions-and-wfa-dosing.md)
* [Hormones — ER-α and Androgens](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/hormones-er-a-and-androgens.md)
* [Terrain Support — Liposomal WFA vs Whole-Plant Ashwagandha](/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/terrain-support-liposomal-wfa-vs-whole-plant-ashwagandha.md)
{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}
{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}
---
# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.
## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/sourcing-quality.md?ask=&goal=
```
`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.